The Foundation of the NLA offers several prominent honors and awards each year that recognize individuals and their research in the field of lipidology and rare and genetic disorders.
Established to honor the founders of the NLA and exemplary clinicians in the field of lipidology.
Supported by the Dyslipidemia Foundation of Boston
Annually awarded to a member of the National Lipid Association who demonstrates continued excellence in clinical care of patients with lipid disorders and/or excellence in education in the field of clinical lipidology.
Supported by the Aaron and Lillie Straus Foundation
Created in honor of the scientist responsible for the discovery of statins, the drug group that has had the greatest demonstrable impact on arteriosclerosis of any pharmacological therapy in the history of medicine, Dr. Akira Endo. This award intends to recognize those responsible for the development of new therapies documented to prevent cardiovascular disease and atherosclerosis.
Supported by Denka-Seiken Corporation, the Dyslipidemia Foundation of Boston, and the Joel Spira Foundation
Recognizes the best submitted abstract in the area of familial hypercholesterolemia (FH) research.
Annually recognizes five (5) young investigators (in training students, residents, and fellows or members in practice for < 5 years) conducting research in the field of lipidology.